Literature DB >> 24880247

Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.

Małgorzata Bondaryk1, Zbigniew Ochal, Monika Staniszewska.   

Abstract

Fungal virulence factors represent a strategy for the design of new compounds with effective activities against Candida spp. Dichloromethyl-4-chloro-3-nitrophenylsulfone (named Compound 1) and chlorodibromomethyl-4-hydrazino-3-nitrophenylsulfone (Compound 2) versus Candida albicans virulence factors (SAP2 expression and adhesion to Caco-2 cell line) were investigated. Candida albicans SC5314 and its mutants: Δsap9, Δsap10, Δsap9/10 were used. MICs of the Compounds (concentrated at 0.0313-16 µg/ml) were determined using M27-A3. Percentage of cell inhibition was assessed spectrophotometrically (OD405) after 48 h at 35 °C. The SAP2 expression was analyzed with the use of RT-PCR; relative quantification was normalized against ACT1 in cells grown in YEPD and on Caco-2. Adherence assay of C. albicans to Caco-2 was performed in a 24-well-plate. Compound 1 showed higher activity (% = 100 at 4 µg/ml) than Compound 2 (MIC90 = 16 µg/ml). Dichloromethyl at the para position of the phenyl ring exerted anti-Candidal potential. Under Compound 1, SAP2 was down-regulated in all the strains (P ≤ 0.05). Conversely, SAP2 was over-expressed in Δsap9-10 (untreated cells) compared with the wild-type. The Compounds significantly affected adherence to epithelium (P ≤ 0.05). The tested sulfones interfered with the adhesion of C. albicans cells to the epithelial tissues without affecting their viability after 90-min of incubation. The Compounds' mode of action was attributed to the reduced adhesiveness and the lower SAP2 expression. Saps9-10 play a role in C. albicans adhesion and they can be involved in the sulfone resistance mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880247     DOI: 10.1007/s11274-014-1676-2

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype.

Authors:  Chiara Calugi; Andrea Trabocchi; Flavia De Bernardis; Silvia Arancia; Pierluigi Navarra; Roberto Cauda; Antonio Cassone; Antonio Guarna
Journal:  Bioorg Med Chem       Date:  2012-10-17       Impact factor: 3.641

3.  Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009.

Authors:  P Zarb; B Amadeo; A Muller; N Drapier; V Vankerckhoven; P Davey; H Goossens
Journal:  Clin Microbiol Infect       Date:  2012-07-24       Impact factor: 8.067

4.  Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.

Authors:  T Wu; K Wright; S F Hurst; C J Morrison
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.

Authors:  M Borg-von Zepelin; I Meyer; R Thomssen; R Würzner; D Sanglard; A Telenti; M Monod
Journal:  J Invest Dermatol       Date:  1999-11       Impact factor: 8.551

6.  Characterisation of Pga1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation.

Authors:  Rami Hashash; Samer Younes; Wael Bahnan; Joseph El Koussa; Katia Maalouf; Hani I Dimassi; Roy A Khalaf
Journal:  Mycoses       Date:  2010-04-06       Impact factor: 4.377

7.  KEX2 influences Candida albicans proteinase secretion and hyphal formation.

Authors:  G Newport; N Agabian
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

Review 8.  Candida albicans drug resistance another way to cope with stress.

Authors:  Richard D Cannon; Erwin Lamping; Ann R Holmes; Kyoko Niimi; Koichi Tanabe; Masakazu Niimi; Brian C Monk
Journal:  Microbiology       Date:  2007-10       Impact factor: 2.777

9.  The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Paulina Zielińska; Zofia Urbańczyk-Lipkowska
Journal:  J Antibiot (Tokyo)       Date:  2014-04-02       Impact factor: 2.649

10.  Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.

Authors:  Vanessa M S Copping; Caroline J Barelle; Bernhard Hube; Neil A R Gow; Alistair J P Brown; Frank C Odds
Journal:  J Antimicrob Chemother       Date:  2005-04-08       Impact factor: 5.790

View more
  1 in total

1.  Role of Virulence Determinants in Candida albicans' Resistance to Novel 2-bromo-2-chloro-2-(4-chlorophenylsulfonyl)-1-phenylethanone.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Zbigniew Ochal
Journal:  J Fungi (Basel)       Date:  2017-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.